Our Services
Medical Information
Helpful Resources
Published on: 9/24/2026
Rhinovirus is the most common cause of the common cold, a highly contagious respiratory virus that infects the nose and throat and spreads through airborne droplets and contaminated surfaces. Symptoms usually include a runny or stuffy nose, sneezing, sore throat, cough, mild headache, and sometimes a low-grade fever, typically appearing 1 to 3 days after exposure. Most rhinovirus infections clear within 7 to 10 days, though a lingering cough or congestion can persist for up to 2 to 3 weeks, and recovery time varies by age, immune health, and whether complications like sinus or ear infections develop. There are several important factors that affect how long it lasts and when symptoms signal something more serious, so see below to understand more.
Because rhinovirus symptoms overlap closely with flu, COVID-19, RSV, allergies, and bacterial infections, guessing can mean waiting too long to get care you actually need. Take a free, instant, online symptom check to better understand what may be causing your symptoms and what practical next steps make sense for you.
Last reviewed for medical accuracy: 09/24/2026
What Is Rhinovirus?
Rhinovirus is one of the most common causes of the “common cold.” It belongs to the Enterovirus genus in the Picornaviridae family. Although it sounds technical, think of rhinovirus simply as a tiny germ that mainly infects the cells lining your nose and throat. Most people catch a rhinovirus infection multiple times throughout their lives—especially in fall and spring—because there are over 100 different strains, and immunity to one doesn’t protect you against the others.
How Rhinovirus Spreads
Rhinovirus is highly contagious. It can spread in several ways:
Typical Symptoms
Symptoms usually develop 1–3 days after exposure. Common signs include:
Most people find these symptoms annoying but manageable. They generally peak around day 3 or 4, then slowly improve.
How Long Does a Rhinovirus Infection Last?
The duration of a rhinovirus infection varies from person to person, but typical timelines are:
Factors that can influence how long you feel unwell include your age, overall health, whether you smoke, and if you have underlying conditions like asthma or allergies.
Managing Symptoms
There’s no cure for rhinovirus, so treatment focuses on making you more comfortable while your body fights off the virus. Key steps include:
Avoid antibiotics unless a bacterial complication develops—these don’t work on viruses.
When to Seek Medical Advice
Most colds clear up on their own, but you should consider talking to a healthcare provider if you experience:
For any life-threatening or serious concerns, always seek immediate medical attention.
Consider a Free, Online Symptom Check
If you’re unsure whether your symptoms warrant a doctor’s visit, try a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you decide on the next best step.
Preventing Rhinovirus Infections
While you can’t avoid every cold, you can reduce your risk:
Possible Complications
Although most rhinovirus infections are mild, complications can occur, particularly in young children, older adults or people with chronic health issues:
Early recognition and prompt treatment of complications can prevent more serious problems.
Key Takeaways
(References)
* Prather AA, Janicki-Deverts D, Hall MH, Cohen S. Behaviorally Assessed Sleep and Susceptibility to the Common Cold. Sleep. 2015 Sep 1;38(9):1353-9. doi: 10.5665/sleep.4968. Epub 2015 Sep 1. PMID: 26118561; PMCID: PMC4531403.
* Engelmann I, Dewilde A, Lazrek M, Batteux M, Hamissi A, Yakoub-Agha I, Hober D. In Vivo Persistence of Human Rhinoviruses in Immunosuppressed Patients. PLoS One. 2017;12(2):e0170774. doi: 10.1371/journal.pone.0170774. Epub 2017 Feb 2. PMID: 28151988; PMCID: PMC5289482.
* Akangire G, Manimtim W, Nyp M, Townley N, Dai H, Norberg M, Taylor JB. Factors leading to rehospitalization for tracheostomized and ventilator-dependent infants through 2 years of age. J Perinatol. 2017 Jul;37(7):857-863. doi: 10.1038/jp.2017.54. Epub 2017 Apr 20. PMID: 28425979.
* Warner SM, Wiehler S, Michi AN, Proud D. Rhinovirus replication and innate immunity in highly differentiated human airway epithelial cells. Respir Res. 2019 Jul 12;20(1):150. doi: 10.1186/s12931-019-1120-0. Epub 2019 Jul 12. PMID: 31299975; PMCID: PMC6626354.
* Brotons P, Jordan I, Bassat Q, Henares D, Fernandez de Sevilla M, Ajanovic S, Redin A, Fumado V, Baro B, Claverol J, Varo R, Cuadras D, Hecht J, Barrabeig I, Garcia-Garcia JJ, Launes C, Muñoz-Almagro C. The Positive Rhinovirus/Enterovirus Detection and SARS-CoV-2 Persistence beyond the Acute Infection Phase: An Intra-Household Surveillance Study. Viruses. 2021 Aug 12;13(8). doi: 10.3390/v13081598. Epub 2021 Aug 12. PMID: 34452462; PMCID: PMC8402816.
* Kim MC, Park JH, Choi SH, Chung JW. Rhinovirus Incidence Rates Indicate We Are Tired of Non-pharmacological Interventions Against Coronavirus Disease 2019. J Korean Med Sci. 2022 Jan 10;37(2):e15. doi: 10.3346/jkms.2022.37.e15. Epub 2022 Jan 10. PMID: 35014227; PMCID: PMC8748668.
* Halabi KC, Stockwell MS, Alba L, Vargas C, Reed C, Saiman L, Mobile Surveillance for Acute Respiratory Infection/Influenza-like Illness in the Community (MoSAIC) Study Team. Clinical and socioeconomic burden of rhinoviruses/enteroviruses in the community. Influenza Other Respir Viruses. 2022 Sep;16(5):891-896. doi: 10.1111/irv.12989. Epub 2022 Apr 29. PMID: 35485187; PMCID: PMC9343330.
* Bahabri I, Abdulaal A, Alanazi T, Alenazy S, Alrumih Y, Alqahtani R, Bosaeed M, Al-Dorzi HM. Characteristics, Management, and Outcomes of Community-Acquired Pneumonia Due to Human Rhinovirus-A Retrospective Study. Can Respir J. 2022;2022:1349994. doi: 10.1155/2022/1349994. Epub 2022 Dec 9. PMID: 36531535; PMCID: PMC9757939.
* Risha MA, Reddy KD, Nemani SSP, Jakwerth C, Schmidt-Weber C, Bahmer T, Hansen G, von Mutius E, Rabe KF, Dittrich AM, Grychtol R, Maison N, Schaub B, Kopp MV, Brinkmann F, Meiners S, Jappe U, Weckmann M, ALLIANCE Study Group as part of the German Centre for Lung Research (DZL). Epigenetic training of human bronchial epithelium cells by repeated rhinovirus infections. Allergy. 2024 Dec;79(12):3385-3400. doi: 10.1111/all.16388. Epub 2024 Nov 8. PMID: 39513674; PMCID: PMC11657021.
* Rosenheim J, Gupta RK, Thakker C, Mann T, Bell LCK, Broderick CM, Madon K, Papargyris L, Dayananda P, Kwok AJ, Greenan-Barrett J, Wagstaffe HR, Conibear E, Fenn J, Hakki S, Lindeboom RGH, Dratva LM, Lemetais B, Weight CM, Venturini C, Kaforou M, Levin M, Kalinova M, Mann AJ, Catchpole A, Knight JC, Nikolić MZ, Teichmann SA, Killingley B, Barclay W, Chain BM, Lalvani A, Heyderman RS, Chiu C, Noursadeghi M. SARS-CoV-2 human challenge reveals biomarkers that discriminate early and late phases of respiratory viral infections. Nat Commun. 2024 Nov 30;15(1):10434. doi: 10.1038/s41467-024-54764-3. Epub 2024 Nov 30. PMID: 39616162; PMCID: PMC11608262.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.